680 related articles for article (PubMed ID: 27913996)
41. Impact of global PTP1B deficiency on the gut barrier permeability during NASH in mice.
Rubio C; Puerto M; García-Rodríquez JJ; Lu VB; García-Martínez I; Alén R; Sanmartín-Salinas P; Toledo-Lobo MV; Saiz J; Ruperez J; Barbas C; Menchén L; Gribble FM; Reimann F; Guijarro LG; Carrascosa JM; Valverde ÁM
Mol Metab; 2020 May; 35():100954. PubMed ID: 32244182
[TBL] [Abstract][Full Text] [Related]
42. PPARα agonist and metformin co-treatment ameliorates NASH in mice induced by a choline-deficient, amino acid-defined diet with 45% fat.
Okishio S; Yamaguchi K; Ishiba H; Tochiki N; Yano K; Takahashi A; Kataoka S; Okuda K; Seko Y; Liu Y; Fujii H; Takahashi D; Ito Y; Kamon J; Umemura A; Moriguchi M; Yasui K; Okanoue T; Itoh Y
Sci Rep; 2020 Nov; 10(1):19578. PubMed ID: 33177546
[TBL] [Abstract][Full Text] [Related]
43. Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.
Ding Y; Sun X; Chen Y; Deng Y; Qian K
Eur J Pharmacol; 2015 Aug; 761():405-12. PubMed ID: 25967348
[TBL] [Abstract][Full Text] [Related]
44. Deletion of nardilysin prevents the development of steatohepatitis and liver fibrotic changes.
Ishizu-Higashi S; Seno H; Nishi E; Matsumoto Y; Ikuta K; Tsuda M; Kimura Y; Takada Y; Kimura Y; Nakanishi Y; Kanda K; Komekado H; Chiba T
PLoS One; 2014; 9(5):e98017. PubMed ID: 24849253
[TBL] [Abstract][Full Text] [Related]
45. GW9662 ameliorates nonalcoholic steatohepatitis by inhibiting the PPARγ/CD36 pathway and altering the gut microbiota.
Xiao J; Xiang H; Xiang H; Sun Z; Xu J; Ren H; Hu P; Peng M
Eur J Pharmacol; 2023 Dec; 960():176113. PubMed ID: 37838102
[TBL] [Abstract][Full Text] [Related]
46. Pectin Alleviates High Fat (Lard) Diet-Induced Nonalcoholic Fatty Liver Disease in Mice: Possible Role of Short-Chain Fatty Acids and Gut Microbiota Regulated by Pectin.
Li W; Zhang K; Yang H
J Agric Food Chem; 2018 Aug; 66(30):8015-8025. PubMed ID: 29987933
[TBL] [Abstract][Full Text] [Related]
47. Susceptibility of Different Mouse Wild Type Strains to Develop Diet-Induced NAFLD/AFLD-Associated Liver Disease.
Fengler VH; Macheiner T; Kessler SM; Czepukojc B; Gemperlein K; Müller R; Kiemer AK; Magnes C; Haybaeck J; Lackner C; Sargsyan K
PLoS One; 2016; 11(5):e0155163. PubMed ID: 27167736
[TBL] [Abstract][Full Text] [Related]
48. Mosapride citrate improves nonalcoholic steatohepatitis with increased fecal lactic acid bacteria and plasma glucagon-like peptide-1 level in a rodent model.
Okubo H; Nakatsu Y; Sakoda H; Kushiyama A; Fujishiro M; Fukushima T; Matsunaga Y; Ohno H; Yoneda M; Kamata H; Shinjo T; Iwashita M; Nishimura F; Asano T
Am J Physiol Gastrointest Liver Physiol; 2015 Jan; 308(2):G151-8. PubMed ID: 25428903
[TBL] [Abstract][Full Text] [Related]
49. Antihypertensive therapy improves insulin resistance and serum levels of interleukin-6 and -10 in spontaneously hypertensive rats with steatohepatitis.
Kozono M; Uto H; Ibusuki R; Arima S; Oda K; Taguchi H; Sasaki F; Nasu Y; Hashimoto S; Setoyama H; Kanmura S; Numata M; Tsubouchi H; Ido A
Mol Med Rep; 2016 Dec; 14(6):5385-5394. PubMed ID: 27779710
[TBL] [Abstract][Full Text] [Related]
50. Enhanced offspring predisposition to steatohepatitis with maternal high-fat diet is associated with epigenetic and microbiome alterations.
Wankhade UD; Zhong Y; Kang P; Alfaro M; Chintapalli SV; Thakali KM; Shankar K
PLoS One; 2017; 12(4):e0175675. PubMed ID: 28414763
[TBL] [Abstract][Full Text] [Related]
51. Structural modulation of gut microbiota during alleviation of non-alcoholic fatty liver disease with Gynostemma pentaphyllum in rats.
Shen SH; Zhong TY; Peng C; Fang J; Lv B
BMC Complement Med Ther; 2020 Feb; 20(1):34. PubMed ID: 32024509
[TBL] [Abstract][Full Text] [Related]
52. CX3CR1 is a gatekeeper for intestinal barrier integrity in mice: Limiting steatohepatitis by maintaining intestinal homeostasis.
Schneider KM; Bieghs V; Heymann F; Hu W; Dreymueller D; Liao L; Frissen M; Ludwig A; Gassler N; Pabst O; Latz E; Sellge G; Penders J; Tacke F; Trautwein C
Hepatology; 2015 Nov; 62(5):1405-16. PubMed ID: 26178698
[TBL] [Abstract][Full Text] [Related]
53. Effects of shenling baizhu powder herbal formula on intestinal microbiota in high-fat diet-induced NAFLD rats.
Zhang Y; Tang K; Deng Y; Chen R; Liang S; Xie H; He Y; Chen Y; Yang Q
Biomed Pharmacother; 2018 Jun; 102():1025-1036. PubMed ID: 29710519
[TBL] [Abstract][Full Text] [Related]
54. Glucagon-like peptide-1 analogue prevents nonalcoholic steatohepatitis in non-obese mice.
Yamamoto T; Nakade Y; Yamauchi T; Kobayashi Y; Ishii N; Ohashi T; Ito K; Sato K; Fukuzawa Y; Yoneda M
World J Gastroenterol; 2016 Feb; 22(8):2512-23. PubMed ID: 26937139
[TBL] [Abstract][Full Text] [Related]
55. Effect of Trifolium pratense extract on methionine-choline-deficient diet-induced steatohepatitis in C57BL/6 mice.
Chen T; Zhong FJ; Hong YM; Su WJ; Zhuang LL; Qiu LX
Chin J Nat Med; 2014 Mar; 12(3):194-8. PubMed ID: 24702805
[TBL] [Abstract][Full Text] [Related]
56. Gut microbiota and bile acids partially mediate the improvement of fibroblast growth factor 21 on methionine-choline-deficient diet-induced non-alcoholic fatty liver disease mice.
Lin D; Sun Q; Liu Z; Pan J; Zhu J; Wang S; Jia S; Zheng M; Li X; Gong F
Free Radic Biol Med; 2023 Feb; 195():199-218. PubMed ID: 36586452
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of Methionine Content in a High-Fat and Choline-Deficient Diet on Body Weight Gain and the Development of Non-Alcoholic Steatohepatitis in Mice.
Chiba T; Suzuki S; Sato Y; Itoh T; Umegaki K
PLoS One; 2016; 11(10):e0164191. PubMed ID: 27723801
[TBL] [Abstract][Full Text] [Related]
58. Nonalcoholic Fatty Liver Disease and the Gut Microbiome.
Boursier J; Diehl AM
Clin Liver Dis; 2016 May; 20(2):263-75. PubMed ID: 27063268
[TBL] [Abstract][Full Text] [Related]
59. Transgenic expression of human neutrophil peptide-1 enhances hepatic fibrosis in mice fed a choline-deficient, L-amino acid-defined diet.
Ibusuki R; Uto H; Arima S; Mawatari S; Setoguchi Y; Iwashita Y; Hashimoto S; Maeda T; Tanoue S; Kanmura S; Oketani M; Ido A; Tsubouchi H
Liver Int; 2013 Nov; 33(10):1549-56. PubMed ID: 23682724
[TBL] [Abstract][Full Text] [Related]
60. Salidroside improves high-fat diet-induced non-alcoholic steatohepatitis by regulating the gut microbiota-bile acid-farnesoid X receptor axis.
Li H; Xi Y; Xin X; Tian H; Hu Y
Biomed Pharmacother; 2020 Apr; 124():109915. PubMed ID: 31986416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
